Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, 3755 Côte Ste-Catherine Road, Montreal, QC, H3T 1E2, Canada; Alberta Precision Laboratories - Calgary and Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, 9-3535 Research Road NW, Calgary, AB T2L 2K8, Canada.
Alberta Precision Laboratories - Calgary and Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, 9-3535 Research Road NW, Calgary, AB T2L 2K8, Canada.
Clin Chim Acta. 2021 Sep;520:202-207. doi: 10.1016/j.cca.2021.06.005. Epub 2021 Jun 5.
Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders that occur due to defects in the steroidogenesis pathway. Approximately 90% of CAH cases can be diagnosed by the measurement of serum 17-hydroxyprogesterone alone. However, the quantification of six additional steroids could significantly improve CAH laboratory diagnosis. Using dried blood spot (DBS) as specimen of choice can further improve patient care due to the small sample volume required for CAH diagnosis in neonates.
An optimized DBS sample preparation method was employed for steroids quantification without the need of derivatization. A LC-MS/MS assay was developed and optimized using a reverse phase-ultra high-pressure liquid chromatography (RP-UHPLC) system combined with triple quadrupole mass spectrometry using positive electrospray ionization mode.
The assay was validated according to CLSI analytical guidelines, including lower limit of quantification (LLOQ), linearity, precision, accuracy, carryover, and method comparison. The analytical measuring range of the method for all steroids was 2.5, 5, or 10 ng/ml to 250 ng/ml in DBS, r ≥ 0.995. The LLOQ, intra-day and inter-day precision were 0.11-1.8 ng/ml, 1.2-6.4 ng/ml, 1.8-11.5%, and 5.3-13.8%, respectively.
Our LC-MS/MS assay simultaneously detects 7 steroids for the diagnosis of CAH and can be readily implemented in clinical laboratories to provide superior analytical performance over traditional immunoassays.
先天性肾上腺皮质增生症(CAH)是一组常染色体隐性疾病,由类固醇生成途径中的缺陷引起。大约 90%的 CAH 病例可以通过单独测量血清 17-羟孕酮来诊断。然而,定量测定另外 6 种类固醇可以显著改善 CAH 的实验室诊断。使用干血斑(DBS)作为首选标本,由于新生儿 CAH 诊断所需的样本量较小,因此可以进一步改善患者的护理。
采用无需衍生化的优化 DBS 样品制备方法进行类固醇定量。采用反相-超高压液相色谱(RP-UHPLC)系统与正电喷雾电离模式下的三重四极杆质谱联用,开发并优化了 LC-MS/MS 检测方法。
该方法根据 CLSI 分析指南进行了验证,包括定量下限(LLOQ)、线性、精密度、准确度、携带污染和方法比较。该方法在 DBS 中的所有类固醇的分析测量范围为 2.5、5 或 10ng/ml 至 250ng/ml,r≥0.995。LLOQ、日内和日间精密度分别为 0.11-1.8ng/ml、1.2-6.4ng/ml、1.8-11.5%和 5.3-13.8%。
我们的 LC-MS/MS 检测方法同时检测 7 种用于 CAH 诊断的类固醇,可以很容易地在临床实验室中实施,提供优于传统免疫测定的分析性能。